Literature DB >> 9485066

Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.

M Mascalchi1, M Tosetti, R Plasmati, M C Bianchi, C Tessa, F Salvi, M Frontali, F Valzania, C Bartolozzi, C A Tassinari.   

Abstract

Linkage and DNA analysis, magnetic resonance (MR) imaging, and single-voxel proton MR spectroscopy were obtained in 10 members of an Italian kindred with spinocerebellar ataxia type 1 (SCA1). The size of the basis pontis, cerebellar hemispheres, middle cerebellar peduncles, and medulla oblongata were decreased in 4 members carrying the SCA1 gene, compared with 6 unaffected subjects. Diffuse signal changes in the pons and cerebellum were observed only in the carrier with the longest disease duration and greatest disability. The N-acetylaspartate/creatine ratio and the choline/creatine ratio in the basis pontis were markedly decreased in 2 symptomatic SCA1 carriers and moderately decreased in 2 asymptomatic SCA1 carriers, compared with the unaffected family members and a control group of 10 healthy volunteers. Minor decreases in the N-acetylaspartate/creatine ratio and the normal choline/creatine ratio were observed in the cerebellar hemisphere of the SCA1 carriers. Reduction of the N-acetylaspartate/creatine ratio, demonstrated by MR spectroscopy in the pons, is likely to reflect a loss of neuronal viability and might represent a biochemical marker of SCA1 more sensitive than brainstem and cerebellum atrophy and signal changes shown by MR imaging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485066     DOI: 10.1002/ana.410430215

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging.

Authors:  D Galanaud; Y Le Fur; F Nicoli; B Denis; S Confort-Gouny; J P Ranjeva; P Viout; J Pelletier; P J Cozzone
Journal:  MAGMA       Date:  2001-10       Impact factor: 2.310

2.  Characteristic signal changes in the pontine base on T2- and multishot diffusion-weighted images in spinocerebellar ataxia type 1.

Authors:  M Adachi; T Kawanami; H Ohshima; T Hosoya
Journal:  Neuroradiology       Date:  2005-10-19       Impact factor: 2.804

Review 3.  Spinocerebellar ataxias.

Authors:  Mario Mascalchi
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

Review 4.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

5.  Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.

Authors:  James M Joers; Dinesh K Deelchand; Tianmeng Lyu; Uzay E Emir; Diane Hutter; Christopher M Gomez; Khalaf O Bushara; Lynn E Eberly; Gülin Öz
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

Review 6.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

7.  Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2.

Authors:  M L Mandelli; T De Simone; L Minati; M G Bruzzone; C Mariotti; R Fancellu; M Savoiardo; M Grisoli
Journal:  AJNR Am J Neuroradiol       Date:  2007 Nov-Dec       Impact factor: 3.825

8.  MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment.

Authors:  P Weybright; P Maly; D Gomez-Hassan; C Blaesing; P C Sundgren
Journal:  Neuroradiology       Date:  2004-04-23       Impact factor: 2.804

9.  Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.

Authors:  Gülin Oz; Diane Hutter; Ivan Tkác; H Brent Clark; Myron D Gross; Hong Jiang; Lynn E Eberly; Khalaf O Bushara; Christopher M Gomez
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

10.  Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Sarah Doss; Alexander U Brandt; Timm Oberwahrenbrock; Matthias Endres; Friedemann Paul; Jan Leo Rinnenthal
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.